In vitro properties of red cells prepared from half-strength citrate CPD/RAS-2 (Erythro-Sol) donations in PL-146 plastic

Transfusion Medicine

Volumn 10, Issue 1, 2000, Pages 31-35

  Hornsey, V S ^a   MacDonald, S ^a   Drummond, O ^a   Bethel, H ^b   Walker, B ^b   Prowse, C V ^a  

^a SCOTTISH NATIONAL BLOOD TRANSFUSION SERVICE   (United Kingdom)

^b ROYAL INFIRMARY OF EDINBURGH   (United Kingdom)

Author keywords

0.5CPD; Additive; Red cell storage

Indexed keywords

ANTICOAGULANT AGENT; BIOMATERIAL; BLOOD CLOTTING FACTOR 8; CITRIC ACID; GLUCOSE; GLUCOSE CITRATE PHOSPHATE; PLASTIC;

ARTICLE; BLOOD DONOR; BLOOD STORAGE; CELL CULTURE; CELL SEPARATION; COMPARATIVE STUDY; CYTOLOGY; ERYTHROCYTE; HUMAN; INSTRUMENTATION; METHODOLOGY;

ANTICOAGULANTS; BIOCOMPATIBLE MATERIALS; BLOOD DONORS; BLOOD PRESERVATION; CELL SEPARATION; CELLS, CULTURED; CITRATES; ERYTHROCYTES; FACTOR VIII; GLUCOSE; HUMANS; PLASTICS;

EID: 0034021106     PISSN: 09587578     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-3148.2000.00229.x     Document Type: Article

References (17)

1. Council of Europe. (1998) Guide to the Preparation, Use and Quality Assurance of Blood Components. Recommendation No. R (95) 15, 4th edn. Council of Europe.
2. Farrugia, A., Douglas, S., James, J. & Whyte, G. (1992) Red cell and platelet concentrates from blood collected into half-strength citrate anticoagulant: improved maintenance of red cell 2,3-diphosphoglycerate in half-citrate red cells. Vox Sanguinis, 63, 31-38.
3. Fitzgerald, R.D., Martin, C.M., Dietz, G.E., Doig, G.S., Potter, R.F. & Sibbald, W.J. (1997) Transfusing red blood cells stored in citrate phosphate dextrose adenine-1 for 28 days fails to improve tissue oxygenation in rats. Critical Care Medicine, 25, 726-732.
4. Griffin, B., Bell, K. & Prowse, C. (1988a) Studies on the procurement of blood coagulation factor VIII: In vivo studies on blood components prepared in half-strength citrate anticoagulant. Vox Sanguinis, 54, 193-198.
5. Griffin, B., Bell, K. & Prowse, C. (1988b) Studies on the procurement of blood coagulation factor VIII: In vitro studies on blood components prepared in half-strength citrate anticoagulant 18 hours after phlebotomy. Vox Sanguinis, 55, 9-13.
6. Heaton, W.A.L. (1986) Enhancement of Cellular Elements. In: New Frontiers in Blood Banking (eds Wallas, C.H. & McCarthy, I.J.), 4, 89-125. American Association of Blood Banks.
7. Heaton, W.A.L. (1992) Evaluation of post transfusion recovery and survival of transfused red cells. Transfusion Medicine Review, VI, 153-169.
8. Högman, C.F., Eriksson, L., Gong, J., Payrat, J.M. & Debrauwere, J. (1993a) Half-strength citrate CPD and new additive solutions for improved blood preservation. 1. Studies of six experimental solutions. Transfusion Medicine, 3, 43-50.
9. Högman, C.F., Eriksson, L., Gong, J., Hgman, A.B., Vikholm, K., Debrauwere, J., Payrat, J.M. & Stewart, M. (1993b) Half-strength citrate CPD combined with a new additive solution for improved storage of red cells suitable for clinical use. Vox Sanguinis, 65, 271-278.
10. Högman, C.F., Eriksson, L., Wallvik, J. & Payrat, J.M. (1997) Clinical and laboratory experience with erythrocyte and platelet preparations from a 0.5CPD Erythro-Sol Opti system. Vox Sanguinis, 73, 212-219.
11. Kimura, H., Hamasaki, N., Yamamoto, M. & Tomonaga, M. (1995) Circulation of red blood cells having high levels of 2,3-biphosphoglycerate protects rat brain from ischemic metabolic changes during hemodilution. Stroke, 26, 1431-1437.
12. McIntosh, R.V. & Foster, P.R. (1990) The effect of solution formulation on the stability and surface interactions of factor VIII during plasma fractionation. Transfusion Science, 11, 55-66.
13. Prowse, C., Waterston, Y.G., Dawes, J. & Farrugia, A. (1987) Studies on the procurement of blood coagulation factor VIII in vitro studies on blood components prepared in half-strength citrate anticoagulant. Vox Sanguinis, 52, 257-264.
14. Prowse, C.V. (1998) Alternatives to human blood and blood resources. Vox Sanguinis, 74 (Suppl. 2), 21-28.
15. Solheim, B.G., Bergerud, U.E., Kjeldsen-Kragh, J., Brosstad, F., Mollnes, T.E., Högman, C.F., Eriksson, L. & Schutz, R. (1998) Improved blood preservation with 0.5CPD erythrosol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood. Vox Sanguinis, 74, 168-175.
16. Suontaka, A.M., Åkerblom, O., Blombäck, M., Eriksson, L., Högman, C.F. & Payrat, J.M. (1996) Stability of blood coagulation factors and inhibitors in blood drawn into half-strength citrate anticoagulant. Vox Sanguinis, 71, 97-102.
17. Weiskopf, R.B. (1998) Do we know when to transfuse red cells to treat acute anemia? Transfusion, 38, 517-521.